S S Gisbertz
Overview
Explore the profile of S S Gisbertz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keywani K, Eshuis W, Borgstein A, van Det M, van Duijvendijk P, van Etten B, et al.
Trials
. 2024 Sep;
25(1):588.
PMID: 39232781
Background: Potentially curative therapy for locally advanced gastric cancer consists of gastrectomy, usually in combination with perioperative chemotherapy. An oncological resection includes a radical (R0) gastrectomy and modified D2 lymphadenectomy;...
2.
Blonk L, Gooszen J, Fakkert R, Eshuis W, Rietveld S, Wierdsma N, et al.
Dis Esophagus
. 2024 Jun;
37(11).
PMID: 38912788
Due to insufficient dietary intake and altered digestion and absorption of nutrients, patients after gastroesophageal cancer surgery are at risk of becoming malnourished and consequently develop micronutrient deficiencies. The aim...
3.
Ketel M, van der Aa D, Henckens S, Rosman C, van Berge Henegouwen M, Klarenbeek B, et al.
Ann Surg Oncol
. 2024 Jun;
31(9):5683-5696.
PMID: 38862837
Background: The optimal extent of lymph node dissection (LND) and the anatomic boundaries per lymph node station (LNS) during minimally invasive esophagectomy (MIE) for esophageal cancer remain a topic of...
4.
Klevebro F, Ash S, Mueller C, Garbarino G, Gisbertz S, van Berge Henegouwen M, et al.
Dis Esophagus
. 2024 Apr;
37(9).
PMID: 38678385
Surgery for cancer of the esophagus or gastro-esophageal junction can be performed with a variety of minimally invasive and open approaches. The left thoracoabdominal esophagectomy (LTE) is an open technique...
5.
Nijssen D, Joosten J, Osterkamp J, van den Elzen R, de Bruin D, Svendsen M, et al.
Surg Endosc
. 2024 Apr;
38(5):2805-2816.
PMID: 38594365
Background: Indocyanine green fluorescence angiography (ICG-FA) may reduce perfusion-related complications of gastrointestinal anastomosis. Software implementations for quantifying ICG-FA are emerging to overcome a subjective interpretation of the technology. Comparison between...
6.
Kroes J, de Haan J, de Haan-Lauteslager M, van Roon E, Derksen S, Manusama E, et al.
Clin Toxicol (Phila)
. 2024 Mar;
62(3):205-207.
PMID: 38501538
No abstract available.
7.
van Doesburg J, Luttikhold J, Lindblad M, van Berge Henegouwen M, Eshuis W, Derks S, et al.
Eur J Surg Oncol
. 2023 Dec;
50(2):107318.
PMID: 38145609
Background: Rapid and complete workup of newly diagnosed esophageal cancer is vital for a timely, individual and high-quality treatment strategy. The aim of this study was to uncover potential delay,...
8.
Soderstrom H, Moons J, Nafteux P, Uzun E, Grimminger P, Luyer M, et al.
Ann Surg Oncol
. 2023 Oct;
30(13):8244-8250.
PMID: 37782412
Background: Studies have shown minimally invasive esophagectomy (MIE) to be a feasible surgical technique in treating esophageal carcinoma. Postoperative complications have been extensively reviewed, but literature focusing on intraoperative complications...
9.
van der Aa D, Gisbertz S, Anderegg M, Lagarde S, Klaassen R, Meijer S, et al.
J Gastrointest Cancer
. 2023 Jul;
55(1):270-280.
PMID: 37393217
Purpose: The curative strategy for patients with esophageal cancer without distant metastases consists of esophagectomy with preceding chemo(radio)therapy (CRT). In 10-40% of patients treated with CRT, no viable tumor is...
10.
Schuring N, Stam W, Plat V, Kalff M, Hulshof M, van Laarhoven H, et al.
Eur J Surg Oncol
. 2023 Jun;
49(10):106947.
PMID: 37355392
Background: Recurrence is frequently observed after esophageal cancer surgery, with dismal post-recurrence survival. Neoadjuvant chemoradiotherapy followed by esophagectomy is the gold standard for resectable esophageal tumors in the Netherlands. This...